Literature DB >> 24952009

CT screening for pulmonary pathology in common variable immunodeficiency disorders and the correlation with clinical and immunological parameters.

L J Maarschalk-Ellerbroek1, P A de Jong, J M van Montfrans, J W J Lammers, A C Bloem, A I M Hoepelman, P M Ellerbroek.   

Abstract

BACKGROUND: Pulmonary disease is common in patients with common variable immunodeficiency disorders (CVID) and involves infections, chronic airway disease and interstitial lung disease. Chronic pulmonary disease is associated with excess morbidity and early mortality and therefore early detection and monitoring of progression is essential. METHODS AND
PURPOSE: Thin slice CT scan and pulmonary function were used to determine the prevalence and spectrum of chronic (pre-clinical) pulmonary disease in adult CVID patients regardless of symptoms. CT Scans were scored for airway abnormalities (AD) and interstitial lung disease (ILD). Other CVID related complications and B and T lymphocyte subsets were analyzed to identify patients at risk for pulmonary disease.
RESULTS: Significant pulmonary abnormalities were detected in 24 of the 47 patients (51%) consisting of AD in 30% and ILD in 34% of cases. In only 7 (29%) of these 24 patients pulmonary function test proved abnormal. The presence of AD was correlated to (recurrent) lower respiratory tract infections despite IgG therapy. The presence of ILD was correlated to autoimmune disease and a reduction in the numbers of CD4 + T cells, naïve CD4 + T cells, naïve CD8 + T cells and memory B cells and lower IgG through levels over time.
CONCLUSION: Preclinical signs of AD and ILD are common in CVID patients despite Ig therapy and do not correlate to pulmonary function testing. Patients at risk for ILD might be identified by the presence of autoimmunity or a deranged T cell pattern. Larger studies are needed to confirm these findings and to determine thresholds for the T lymphocyte subsets.

Entities:  

Mesh:

Year:  2014        PMID: 24952009     DOI: 10.1007/s10875-014-0068-6

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  67 in total

Review 1.  Immunoglobulin treatment in primary antibody deficiency.

Authors:  L J Maarschalk-Ellerbroek; I M Hoepelman; P M Ellerbroek
Journal:  Int J Antimicrob Agents       Date:  2011-01-26       Impact factor: 5.283

2.  SWAB/NVALT (Dutch Working Party on Antibiotic Policy and Dutch Association of Chest Physicians) guidelines on the management of community-acquired pneumonia in adults.

Authors:  W J Wiersinga; M J Bonten; W G Boersma; R E Jonkers; R M Aleva; B J Kullberg; J A Schouten; J E Degener; R Janknegt; T J Verheij; A P E Sachs; J M Prins
Journal:  Neth J Med       Date:  2012-03       Impact factor: 1.422

3.  Infection outcomes in patients with common variable immunodeficiency disorders: relationship to immunoglobulin therapy over 22 years.

Authors:  Mary Lucas; Martin Lee; Jenny Lortan; Eduardo Lopez-Granados; Siraj Misbah; Helen Chapel
Journal:  J Allergy Clin Immunol       Date:  2010-05-14       Impact factor: 10.793

4.  Confirmation and improvement of criteria for clinical phenotyping in common variable immunodeficiency disorders in replicate cohorts.

Authors:  Helen Chapel; Mary Lucas; Smita Patel; Martin Lee; Charlotte Cunningham-Rundles; Elena Resnick; Laurence Gerard; Eric Oksenhendler
Journal:  J Allergy Clin Immunol       Date:  2012-07-20       Impact factor: 10.793

5.  Development of pulmonary abnormalities in patients with common variable immunodeficiency: associations with clinical and immunologic factors.

Authors:  Stina Gregersen; Trond Mogens Aaløkken; Georg Mynarek; Børre Fevang; Are Martin Holm; Thor Ueland; Pål Aukrust; Johny Kongerud; Bjørn Johansen; Stig S Frøland
Journal:  Ann Allergy Asthma Immunol       Date:  2010-06       Impact factor: 6.347

6.  The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia. A randomized, double-blind, multicenter crossover trial.

Authors:  H W Eijkhout; J W van Der Meer; C G Kallenberg; R S Weening; J T van Dissel; L A Sanders; P F Strengers; H Nienhuis; P T Schellekens
Journal:  Ann Intern Med       Date:  2001-08-07       Impact factor: 25.391

7.  High resolution computed tomography and pulmonary function in common variable immunodeficiency.

Authors:  Stina Gregersen; Trond Mogens Aaløkken; Georg Mynarek; Johny Kongerud; Pål Aukrust; Stig S Frøland; Bjørn Johansen
Journal:  Respir Med       Date:  2009-02-01       Impact factor: 3.415

Review 8.  Common variable immunodeficiency: etiological and treatment issues.

Authors:  Sean Deane; Carlo Selmi; Stanley M Naguwa; Suzanne S Teuber; M Eric Gershwin
Journal:  Int Arch Allergy Immunol       Date:  2009-07-01       Impact factor: 2.749

9.  Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates with clinical aspects.

Authors:  B Piqueras; C Lavenu-Bombled; L Galicier; F Bergeron-van der Cruyssen; L Mouthon; S Chevret; P Debré; C Schmitt; E Oksenhendler
Journal:  J Clin Immunol       Date:  2003-09       Impact factor: 8.317

10.  Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency.

Authors:  Isabella Quinti; Annarosa Soresina; Giuseppe Spadaro; Silvana Martino; Simona Donnanno; Carlo Agostini; Pignata Claudio; Dammacco Franco; Anna Maria Pesce; Federica Borghese; Andrea Guerra; Roberto Rondelli; Alessandro Plebani
Journal:  J Clin Immunol       Date:  2007-02-14       Impact factor: 8.542

View more
  22 in total

1.  International Consensus Document (ICON): Common Variable Immunodeficiency Disorders.

Authors:  Francisco A Bonilla; Isil Barlan; Helen Chapel; Beatriz T Costa-Carvalho; Charlotte Cunningham-Rundles; M Teresa de la Morena; Francisco J Espinosa-Rosales; Lennart Hammarström; Shigeaki Nonoyama; Isabella Quinti; John M Routes; Mimi L K Tang; Klaus Warnatz
Journal:  J Allergy Clin Immunol Pract       Date:  2015-11-07

2.  Immunologist's Perspectives on Assessment and Management of Lung Disease in CVID: a Survey of the Membership of the Clinical Immunology Society and the European Society for Immunodeficiencies.

Authors:  Javeed Akhter; Cheryl A Lefaiver; Christopher Scalchunes; Michael DiGirolamo; Klaus Warnatz
Journal:  J Clin Immunol       Date:  2018-04-08       Impact factor: 8.317

3.  BAFF-driven B cell hyperplasia underlies lung disease in common variable immunodeficiency.

Authors:  Paul J Maglione; Gavin Gyimesi; Montserrat Cols; Lin Radigan; Huaibin M Ko; Tamar Weinberger; Brian H Lee; Emilie K Grasset; Adeeb H Rahman; Andrea Cerutti; Charlotte Cunningham-Rundles
Journal:  JCI Insight       Date:  2019-03-07

4.  Granulomatous and lymphocytic interstitial lung disease: a spectrum of pulmonary histopathologic lesions in common variable immunodeficiency--histologic and immunohistochemical analyses of 16 cases.

Authors:  Nagarjun Rao; A Craig Mackinnon; John M Routes
Journal:  Hum Pathol       Date:  2015-06-01       Impact factor: 3.466

5.  Interstitial lung disease in patients with common variable immunodeficiency disorders: several different pathologies?

Authors:  S Patel; C Anzilotti; M Lucas; N Moore; H Chapel
Journal:  Clin Exp Immunol       Date:  2019-07-10       Impact factor: 4.330

6.  Cellular Defects in CVID Patients with Chronic Lung Disease in the USIDNET Registry.

Authors:  Erinn S Kellner; Ramsay Fuleihan; Charlotte Cunningham-Rundles; Joshua B Wechsler
Journal:  J Clin Immunol       Date:  2019-06-27       Impact factor: 8.317

7.  Pulmonary Manifestations of the Autoimmune Lymphoproliferative Syndrome. A Retrospective Study of a Unique Patient Cohort.

Authors:  Chuen-Yen Lau; Andrew D Mihalek; Jing Wang; Lori E Dodd; Katie Perkins; Susan Price; Sharon Webster; Stefania Pittaluga; Les R Folio; V Koneti Rao; Kenneth N Olivier
Journal:  Ann Am Thorac Soc       Date:  2016-08

Review 8.  Management of granulomatous lymphocytic interstitial lung disease in a patient with common variable immune deficiency.

Authors:  Mohini Pathria; Daniel Urbine; Marc Stuart Zumberg; Juan Guarderas
Journal:  BMJ Case Rep       Date:  2016-06-22

9.  Bronchiectasis and deteriorating lung function in agammaglobulinaemia despite immunoglobulin replacement therapy.

Authors:  A Stubbs; C Bangs; B Shillitoe; J D Edgar; S O Burns; M Thomas; H Alachkar; M Buckland; E McDermott; G Arumugakani; S Jolles; R Herriot; P D Arkwright
Journal:  Clin Exp Immunol       Date:  2017-11-03       Impact factor: 4.330

Review 10.  Chronic Lung Disease in Primary Antibody Deficiency: Diagnosis and Management.

Authors:  Paul J Maglione
Journal:  Immunol Allergy Clin North Am       Date:  2020-06-09       Impact factor: 3.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.